【Highlights】Genicore’s Successful Showcase at BIOCHINA 2026
3/20/26, 1:00 AM
Expanding Globally: Genicore at BIOCHINA 2026
Collaborating with our distributor, Genicore showcased our next-gen solutions at BIOCHINA 2026 in Suzhou. This milestone exhibition allowed us to deepen ties with end-customers and capture critical market dynamics to fast-track our cross-border expansion.
Deepening Exosome Expertise: One-Stop Purification & Detection Solutions
During the exhibition, Genicore showcased high-performance workflows targeting exosomes—the frontier of biopharma and precision medicine:
Exosome Purification: Delivers high purity and active recovery, drawing strong interest from researchers focused on downstream functional assays.
Exosome ELASA Detection: Combines high sensitivity and specificity with cost-efficiency. It enables precise quantification of surface markers in precious, limited biological samples, solving the traditional bottleneck of high costs and sample scarcity.
Securing the Foundation of Protein Research: His-tag Purification
Alongside our advanced exosome technologies, Genicore presented our core His-tag purification series. Featuring excellent binding capacity and minimal non-specific binding, this lineup maintains a strong competitive edge in the recombinant protein market, attracting multiple inquiries for large-scale industrial applications.
"We are thrilled to see our technical solutions meet the clinical and research demands for efficiency and precision. Genicore will continue to optimize our portfolio and collaborate closely with global partners to deliver superior service."
